Contact
searchSearch
HMP Global

AIBD APP Institute

Featured

Laura Raffals
Conference Coverage
Laura Raffals, MD, on Choosing Therapy for Crohn's After Initial Failure
12/09/2025
Laura Raffals
Dr Raffals explains a framework for choosing a second therapy for the patient with Crohn's disease who did not respond, or lost response, to the first therapy.
Dr Raffals explains a framework for choosing a second therapy for the patient with Crohn's disease who did not respond, or lost response, to the first therapy.
Dr Raffals explains a framework...
12/09/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on Updates in Post-Operative Crohn's Disease
12/09/2025
Miguel D. Regueiro, MD
Dr Regueiro provides updates on the care--and possible prevention of recurrence—of Crohn's disease following surgery, from his presentation at the 2025 AIBD Annual Meeting in Orlando, Florida.
Dr Regueiro provides updates on the care--and possible prevention of recurrence—of Crohn's disease following surgery, from his presentation at the 2025 AIBD Annual Meeting in Orlando, Florida.
Dr Regueiro provides updates on...
12/09/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Conference Coverage
Joshua Steinberg, MD, on Complex Cases in IBD
12/07/2025
Joshua Steinberg, MD
Dr Steinberg discusses his presentation at the AIBD APP Institute of two complex cases, one of a patient with acute severe ulcerative colitis and another on a patient with penetrating and stricturing Crohn's disease.
Dr Steinberg discusses his presentation at the AIBD APP Institute of two complex cases, one of a patient with acute severe ulcerative colitis and another on a patient with penetrating and stricturing Crohn's disease.
Dr Steinberg discusses his...
12/07/2025
AIBD APP Institute
APP Perspectives
Sarah Massey, APN, on Diagnosing and Monitoring Patients With IBD
12/07/2025
Sarah Massey, APN
Sarah Massey, MSN, APRN, FNP-C is a board-certified nurse practitioner specializing in the care of patients with inflammatory bowel disease (IBD). She currently practics at the University of Chicago
Sarah Massey, MSN, APRN, FNP-C is a board-certified nurse practitioner specializing in the care of patients with inflammatory bowel disease (IBD). She currently practics at the University of Chicago
Sarah Massey, MSN, APRN, FNP-C...
12/07/2025
AIBD APP Institute
Conference Coverage
Jennifer Labas, APN, on Managing the Hospitalized Patient With IBD
12/07/2025
Jennifer Labas, APN
Jennifer Labas, APN, reviews her presentation on caring for patients who require hospitalization for Crohn's disease or ulcerative colitis.
Jennifer Labas, APN, reviews her presentation on caring for patients who require hospitalization for Crohn's disease or ulcerative colitis.
Jennifer Labas, APN, reviews her...
12/07/2025
AIBD APP Institute
IBD Drive Time
Podcast
IBD Drive Time: Florian Rieder, MD, on Stricturing and Penetrating Crohn's Disease
10/06/2025
Raymond Cross, MD; Florian Rieder
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes...
10/06/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Research Highlights
Guselkumab Demonstrates Efficacy and Safety in Moderate-to-Severe Crohn’s Disease
09/04/2025
Jessica Garlewicz
The study met all primary and multiplicity-controlled secondary endpoints, including clinical and endoscopic outcomes through 48 weeks.
The study met all primary and multiplicity-controlled secondary endpoints, including clinical and endoscopic outcomes through 48 weeks.
The study met all primary and...
09/04/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Uma Mahadevan, MD
PIANO Global Consensus
Dr Uma Mahadevan on the PIANO Global Consensus on Pregnancy in IBD
08/28/2025
Uma Mahadevan, MD
Dr Uma Mahadevan, the principal investigator for the PIANO registry of IBD in pregnancy, introduces a series of reports on the Global Consensus for this groundbreaking study of the impacts of IBD and medications on fertility, conception,...
Dr Uma Mahadevan, the principal investigator for the PIANO registry of IBD in pregnancy, introduces a series of reports on the Global Consensus for this groundbreaking study of the impacts of IBD and medications on fertility, conception,...
Dr Uma Mahadevan, the principal...
08/28/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
News
Validation of a Simple Ultrasound Score for Crohn’s Disease
08/28/2025
Rebecca Mashaw
A multicenter study confirms the accuracy and reliability of a simplified ultrasound score for assessing Crohn’s disease activity.
A multicenter study confirms the accuracy and reliability of a simplified ultrasound score for assessing Crohn’s disease activity.
A multicenter study confirms the...
08/28/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Shirley Cohen Mekelburg
Conference Coverage
Shirley Cohen-Mekelburg, MD, on Penetrating and Stricturing Crohn's Disease
08/25/2025
Shirley Cohen-Mekelburg
Dr Cohen-Mekelburg recaps the key takeaways from her presentation at the AIBD regional meeting in Detroit on managing penetrating and stricturing Crohn's disease and perianal disease.
Dr Cohen-Mekelburg recaps the key takeaways from her presentation at the AIBD regional meeting in Detroit on managing penetrating and stricturing Crohn's disease and perianal disease.
Dr Cohen-Mekelburg recaps the...
08/25/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Conference Coverage
Positioning Advanced Therapies in Ulcerative Colitis
08/14/2025
Rebecca Mashaw
Disease activity and severity, along with patient buy-in, are the most important factors to consider when choosing therapy for ulcerative colitis, said Angelina Collins, MSN, ANP-BC, in her presentation to the APP IBD Institute virtual...
Disease activity and severity, along with patient buy-in, are the most important factors to consider when choosing therapy for ulcerative colitis, said Angelina Collins, MSN, ANP-BC, in her presentation to the APP IBD Institute virtual...
Disease activity and severity,...
08/14/2025
AIBD APP Institute

Clinical Pearls

Conference Coverage
Jamie Brogan, APRN, on Extraintestinal Manifestations of IBD
07/31/2025
Jamie Brogan, APRN
Jamie Brogan, APRN, reviews her presentation on identifying and treating the most frequently seen extraintestinal manifestations among patients with inflammatory bowel disease.
Jamie Brogan, APRN, reviews her presentation on identifying and treating the most frequently seen extraintestinal manifestations among patients with inflammatory bowel disease.
Jamie Brogan, APRN, reviews her...
07/31/2025
Advances in Inflammatory Bowel Disease Network
David Rubin
Clinical Pearls
David Rubin, MD, on the GALAXI 2 and 3 Trials of Guselkumab in Crohn's Disease
05/06/2025
David T. Rubin, MD
Dr Rubin reviews the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to biologics. 
Dr Rubin reviews the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to biologics. 
Dr Rubin reviews the results of...
05/06/2025
AIBD APP Institute
Jim Lewis
Clinical Pearls
James D. Lewis, MD, on Diet and Nutrition in Crohn's Disease
04/11/2025
James D. Lewis
Dr James D. Lewis recaps his presentation on using diet —including the Crohn's Disease Exclusion Diet, the Low FODmap Diet, and the Mediterranean diet—as an adjunct to medical therapy for Crohn's disease, and the potential for diet to perhaps...
Dr James D. Lewis recaps his presentation on using diet —including the Crohn's Disease Exclusion Diet, the Low FODmap Diet, and the Mediterranean diet—as an adjunct to medical therapy for Crohn's disease, and the potential for diet to perhaps...
Dr James D. Lewis recaps his...
04/11/2025
AIBD APP Institute
Marla Dubinsky
Clinical Pearls
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
04/11/2025
Marla C. Dubinsky, MD
Dr Dubinsky stresses that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies—which do not include 5-ASAs— to help prevent complications and change the natural history of...
Dr Dubinsky stresses that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies—which do not include 5-ASAs— to help prevent complications and change the natural history of...
Dr Dubinsky stresses that...
04/11/2025
AIBD APP Institute
Uma Mahadevan, MD
Clinical Pearls
Caring for the Pregnant Patient With IBD
02/26/2024
Uma Mahadevan
Dr Uma Mahadevan discusses the key factors to consider when caring for patients with inflammatory bowel disease who are or who want to become pregnant.
Dr Uma Mahadevan discusses the key factors to consider when caring for patients with inflammatory bowel disease who are or who want to become pregnant.
Dr Uma Mahadevan discusses the...
02/26/2024
AIBD APP Institute
David Rubin
Clinical Pearls
Dose Optimization of Anti-TNF Therapy for IBD
02/26/2024
Dr David Rubin provides a guideline for optimizing adalimumab and infliximab in treating patients with inflammatory bowel disease.
Dr David Rubin provides a guideline for optimizing adalimumab and infliximab in treating patients with inflammatory bowel disease.
Dr David Rubin provides a...
02/26/2024
AIBD APP Institute
Laura Raffals
Clinical Pearls
Top Clinical Pearls for Managing Ulcerative Colitis
01/21/2023
Dr Laura Raffals from Mayo Clinic discusses her top clinical tips for ensuring proper diagnosis, treatment, monitoring, and management of patients with ulcerative colitis.
Dr Laura Raffals from Mayo Clinic discusses her top clinical tips for ensuring proper diagnosis, treatment, monitoring, and management of patients with ulcerative colitis.
Dr Laura Raffals from Mayo...
01/21/2023
AIBD APP Institute

APP Perspectives

Marita Kametas
APP Perspectives
Welcome to the APP Institute Inflammatory Bowel Disease!
03/01/2024
Marita Kametas, MSN, APN, introduces the new APP Institute Inflammatory Bowel DIsease and gives a brief overview of the content offerings for advanced practice providers in the IBD field.
Marita Kametas, MSN, APN, introduces the new APP Institute Inflammatory Bowel DIsease and gives a brief overview of the content offerings for advanced practice providers in the IBD field.
Marita Kametas, MSN, APN,...
03/01/2024
AIBD APP Institute
Kim Orleck
APP Perspectives
Tracking Productivity in IBD Care for APPs
02/26/2024
Kimberly Orleck reviews how much of an APP's work in an IBD practice may not be carefully tracked or compensated for, and how to
Kimberly Orleck reviews how much of an APP's work in an IBD practice may not be carefully tracked or compensated for, and how to
Kimberly Orleck reviews how much...
02/26/2024
AIBD APP Institute

Rapid Refresh

Marita Kametas
Rapid Refresh
Marita Kametas, MSN, on Disease Severity vs Activity in Crohn's Disease
04/21/2025
Marita Kametas, MSN-RN
APP Marita Kametas, MSN, from the University of Chicago, provides an overview of disease severity and disease activity in Crohn's disease.
APP Marita Kametas, MSN, from the University of Chicago, provides an overview of disease severity and disease activity in Crohn's disease.
APP Marita Kametas, MSN, from...
04/21/2025
AIBD APP Institute
Kim Kearns
Video
Kimberly Kearns, MS, APRN, on Diagnostics in IBD
07/01/2024
Kimberly Kearns, ANP-BC
Kimberly Kearns, MS, APN-BC, delves into the noninvasive and invasive diagnostic tools available to APPs working with patients who have or are suspected of having inflammatory bowel disease.
Kimberly Kearns, MS, APN-BC, delves into the noninvasive and invasive diagnostic tools available to APPs working with patients who have or are suspected of having inflammatory bowel disease.
Kimberly Kearns, MS, APN-BC,...
07/01/2024
AIBD APP Institute
Marita Kametas
Rapid Refresh
Severity vs Activity in IBD
06/26/2024
Marita Kametas, MSN, APN, continues her tutorial on IBD with a review of the disease severity and disease activity, including how they differ and how they can be assessed.
Marita Kametas, MSN, APN, continues her tutorial on IBD with a review of the disease severity and disease activity, including how they differ and how they can be assessed.
Marita Kametas, MSN, APN,...
06/26/2024
AIBD APP Institute
Marita Kametas
Rapid Refresh
UC or CD: What's the Difference?
06/26/2024
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from...
06/26/2024
AIBD APP Institute

Visit Our Other APP Institutes

APP Institute Advances in Inflammatory Bowel Disease

The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of care for patients with inflammatory bowel disease (IBD).

The APP Institute | Advances in Inflammatory Bowel Disease is designed for Advanced Practice Providers who specialize in Inflammatory Bowel Diseases, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with IBD.

November 11-12, 2026 | Register Now

 

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use